| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/26/2005 | CN1569054A Dripping pills of 'Xiao Chaihu' |
| 01/26/2005 | CN1569050A Novel preparing technique of |
| 01/26/2005 | CN1569049A Novel preparing method of |
| 01/26/2005 | CN1569048A Novel method for preparing headache and vertigo treating medicine and its preparation |
| 01/26/2005 | CN1569047A Novel method for preparing a liver benefiting medicine and its preparation |
| 01/26/2005 | CN1569046A Novel method for preparing a liver benefiting medicine and its preparation |
| 01/26/2005 | CN1569045A Novel preparation technique and formulation of 'Buzhon Yiqi' |
| 01/26/2005 | CN1569044A Healthy product raw liquor of armilariella tabescens for strengthening the body and protecting the liver and method for improving the formulation of armilariella tabescens |
| 01/26/2005 | CN1569022A Dripping pills of lentinan and its preparing process |
| 01/26/2005 | CN1569005A Enteric-coated formulation of glycyrrhizic acid and its salt and its preparing method |
| 01/26/2005 | CN1569004A Dripping pills of nefopam hydrochloride and its preparation method |
| 01/26/2005 | CN1568989A Dripping pill of loperamide hydrochloride and its preparation method |
| 01/26/2005 | CN1568980A Dripping pills of compound allantoin |
| 01/26/2005 | CN1568972A Dripping pills of armillarisin A and its preparation method |
| 01/26/2005 | CN1568970A Dripping pills of andrographolide and its preparing method |
| 01/26/2005 | CN1568956A Compound diisopropylamine dichloroacetate powder and injection prreparations |
| 01/26/2005 | CN1568955A Compound diisopropylamine dichloroacetate transfusion liquid |
| 01/26/2005 | CN1568954A Mesalazine colon target releasing micro pills and preparation method thereof |
| 01/26/2005 | CN1186445C Light chain or heavy chain variable region gene of human liver cancer monoclonal antibody HAb18 and its application |
| 01/26/2005 | CN1186438C Health care and nourishing life wine and its making method |
| 01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
| 01/26/2005 | CN1186091C Liver disease treating injection and its production process |
| 01/26/2005 | CN1186089C Dizziness treating Chinese medicine |
| 01/26/2005 | CN1186081C Granula formulated medicine for freeing yang and resisting fatigue and its preparation method |
| 01/26/2005 | CN1186072C Health wine for expelling wind, clearing away cold and removing dampness |
| 01/26/2005 | CN1186064C Medicine for treating hepatopathy and its preparation process |
| 01/26/2005 | CN1186057C Chinese medicinal pill for reinforcing kidney and strengthening yang, warming and recuperating qi and blood, and improving organism immunity |
| 01/26/2005 | CN1186044C Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis |
| 01/26/2005 | CN1186037C Medicine for treating hepatitis |
| 01/26/2005 | CN1186035C Health food capsule with functions of sobering up, detoxicating, nourishing heart, tranquilizing and protecting liver and its production process |
| 01/26/2005 | CN1186022C Medicine for oral disease |
| 01/25/2005 | US6846906 Modified proteins of the TGF-β superfamily, including morphogenic proteins |
| 01/25/2005 | US6846832 Highly selective monoamine oxidase B inhibitors; treating Alzheimer's disease, Parkinson's disease, and senile dementia |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | US6846828 Aminopyrimidine and aminopyridine anti-inflammation agents |
| 01/25/2005 | US6846827 Antiinflammatory agents; antiallergens; antiarthritic agents |
| 01/25/2005 | US6846811 For treating psoriasis, inflammation, leukemia, colon cancer, breast cancer or prostate cancer |
| 01/25/2005 | US6846499 Medical effect of jojoba oil |
| 01/20/2005 | WO2005005383A1 Amino alcohol compound |
| 01/20/2005 | WO2005004990A1 Use of whey permeate for the treatment of metabolic syndrome |
| 01/20/2005 | WO2005004881A1 Use of ribofuranose derivatives against inflammatory bowel diseases |
| 01/20/2005 | WO2005004873A1 Use of antivirals against inflammatory bowel diseases |
| 01/20/2005 | WO2005004857A1 Method for treating acute pancreatitis |
| 01/20/2005 | WO2005004639A1 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 01/20/2005 | WO2004089992A8 Modified acacia and use thereof |
| 01/20/2005 | WO2004069142A3 Anti-candida agents for the treatment of prion diseases |
| 01/20/2005 | WO2004038408A3 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
| 01/20/2005 | US20050015820 Using transgenic mouse tissue as model for monitoring agents that affect appetite, energy expenditure and caloric and food intake; dietetics and weight gain |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
| 01/20/2005 | US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase |
| 01/20/2005 | US20050014833 Cyclic compound and ppar agonist |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014781 Ring fused pyrazole derivatives as CRF antagonists |
| 01/20/2005 | US20050014741 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 01/20/2005 | US20050014717 Composition and method for viral inhibition |
| 01/20/2005 | US20050014705 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/20/2005 | US20050014701 Synergistic mixture; anticoagulants |
| 01/20/2005 | US20050014699 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 01/20/2005 | US20050014693 Transmission and, or amplification of signals; oral or enteric administering, dissolving, absorption of peptide yy; obesity therapy |
| 01/20/2005 | US20050014686 Somatostatin analogues |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014188 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 01/20/2005 | US20050013821 Mint extract and related pharmaceutical compositions |
| 01/20/2005 | US20050013801 Concurrently administering Interferon alpha and gamma; reducing incidence of complications |
| 01/20/2005 | CA2532833A1 Use of whey permeate for the treatment of metabolic syndrome |
| 01/20/2005 | CA2528144A1 Method for treating acute pancreatitis |
| 01/19/2005 | EP1498135A1 Dental viscous pharmaceutical containing basic fibroblast growth factor |
| 01/19/2005 | EP1498134A1 Helicobacter pylori adhesion inhibitor |
| 01/19/2005 | EP1498125A1 Use of compounds having ccr antagonism |
| 01/19/2005 | EP1498039A1 Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods |
| 01/19/2005 | EP1497662A1 Uses of the carbamoyl phosphate synthesis 1 (cps 1) and the fragments thereof for the diagnosis of inflammatory diseases and sepsis |
| 01/19/2005 | EP1497656A2 Diagnosis of carcinoma using raig1 polypeptides |
| 01/19/2005 | EP1497435A2 Placental derived stem cells and uses thereof |
| 01/19/2005 | EP1497401A1 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes |
| 01/19/2005 | EP1497322A2 Treatment of infections and other disorders |
| 01/19/2005 | EP1497315A2 Nucleic acid-associated proteins |
| 01/19/2005 | EP1497296A1 1,4 DIAZOCINO 7,8,1-hi INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS |
| 01/19/2005 | EP1497294A1 1,2,3,4,7,8-HEXAHYDRO-6 i H /i - 1,4 DIAZEPINO 6,7 ,1- i 1J /i QUINOLINE DERIVATIVES AS ANTIPSYCHOTIC AND ANTI OBESITY AGENTS |
| 01/19/2005 | EP1497293A1 (1,4)diazepino(6,7,1-ij)quinoline derivatives as anti psychotic and antiobesity agents |
| 01/19/2005 | EP1497288A1 Novel ester hydroxy-substituted nitrogen heterocycles as antagonists of the muscarinic m3 receptor, methods for the production thereof, and use thereof as a medicament |
| 01/19/2005 | EP1497285A1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 01/19/2005 | EP1497284A2 Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors |
| 01/19/2005 | EP1497282A2 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4 protease |
| 01/19/2005 | EP1497279A2 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 01/19/2005 | EP1497274A2 Terphenyl derivatives, preparation thereof, compositions containing same |
| 01/19/2005 | EP1497273A2 Hydroxamic acid derivatives |
| 01/19/2005 | EP1497269A1 Substituted 2-phenyl-3(2h)-pyridazinones |
| 01/19/2005 | EP1497268A2 Nitric oxide donors, compositions and methods of use |
| 01/19/2005 | EP1497265A1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 01/19/2005 | EP1497261A1 Phenethanolamine derivatives |
| 01/19/2005 | EP1497256A1 Substituted 1,5-diaminopentan-3-ol compounds |
| 01/19/2005 | EP1497247A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses |
| 01/19/2005 | EP1497019A1 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/19/2005 | EP1496941A1 Glycodendrimers having biological activity |
| 01/19/2005 | EP1496940A2 Methods of treating diabetes using pde 11a inhibitors |